These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 628669)

  • 1. [Effect of the properties of gelatin on the quality of solution of the plasma substitute gelatinol].
    Chuprasov VK; Znamenskaia TV; Radkevich D
    Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):53-5. PubMed ID: 628669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of molecular weight of plasma substitute, gelatinol solution, by the viscosimetric method].
    Shlimak VM; Znamenskaia TV; Lazareva IV; Dmitrenko LV; Kallistov OV
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):56-8. PubMed ID: 1025553
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the effect of a plasma-substituting solution, gelatinol, on liver function. (Experimental study)].
    Khlebnikova IM; Znamenskaia TV
    Probl Gematol Pereliv Krovi; 1965 Aug; 10(8):50-3. PubMed ID: 5869006
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood substitute gelatinol (experimental-clinical study)].
    Pushkar' LN; Gerasimova LI; Troitskiĭ VB
    Voen Med Zh; 1966 Jul; 7():14-6. PubMed ID: 5999449
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiogel. Chemical and physio-chemical properties].
    Beutl K; Roggen G; Nitschmann H
    Helv Chir Acta; 1966 May; 33(3):343-7. PubMed ID: 5994655
    [No Abstract]   [Full Text] [Related]  

  • 6. Gelatin as starting material for the manufacture of plasma substitute preparations.
    Nitschmann H; Stoll HR
    Bibl Haematol; 1969; 33():55-74. PubMed ID: 5384022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Does gelatin as a blood substitute selectively depress plasma fibronectin? A clinical randomized study].
    Lackner F; Graninger W; Khosropour R
    Anaesthesist; 1985 Sep; 34(9):470-3. PubMed ID: 3909842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption.
    ten Dam MA; Branten AJ; Klasen IS; Wetzels JF
    J Crit Care; 2001 Sep; 16(3):115-20. PubMed ID: 11689768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation studies on a 4 per cent gelatin solution containing 1 per cent glycine for intravenous use.
    Gabr Y; Saleeb F; Osman M
    Arzneimittelforschung; 1967 May; 17(5):643-5. PubMed ID: 5631598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of gelatinol in the erythrocytic transfusion media for extracorporeal circulation].
    Shulutko LS; Mikhnovich EP; Antonova EV
    Probl Gematol Pereliv Krovi; 1970 Sep; 15(9):57-9. PubMed ID: 5502493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical plasma substitution with gelatin: A 12-year experience with 39,320 units of Physiogel].
    Tschirren B; Affolter U; Elsässer R; Frehofer UA; Grawehr R; Müller PH; Lundsgaard-Hansen P
    Infusionstherapie (1973); 1974 Dec; 1(8):651-62. PubMed ID: 4142946
    [No Abstract]   [Full Text] [Related]  

  • 14. [Obtaining dry gelatinol and a study of its properties].
    Bogomolova LG; Znamenskaia TV; Suslov VS; Podol'skiĭ MV; Vorontsova NA
    Probl Gematol Pereliv Krovi; 1976 Aug; 21(8):28-30. PubMed ID: 967840
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plant technology for salt plasma substitute concentrates and a study of their stability].
    Shpak RS; Vaĭsman GA; Stoliarova GG
    Farm Zh; 1973; 28(3):41-3. PubMed ID: 4774706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic hemodynamics and oxygen supply to the body in moderate and severe hemodilution induced by gelatinol].
    Kolonina IR
    Patol Fiziol Eksp Ter; 1980; (1):83-4. PubMed ID: 7375168
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of the gelatin expander physiogel on kidney function].
    Cottier P; Basevi A; Schafroth HJ
    Helv Chir Acta; 1966 May; 33(3):383-91. PubMed ID: 5994658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional and histological studies of the effect of a modified high molecular weight gelatin preparation on the kidneys].
    Hölscher B
    Chirurg; 1968 May; 39(5):228-30. PubMed ID: 5715439
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Soviet colloid modegel as a component of a perfusion medium used in surgery with extracorporeal circulation].
    Lur'e GO; Mal'tseva AIu; Osipov VP; Khodas MIa; Piatnitskaia GKh; Andrianova MIu
    Anesteziol Reanimatol; 1991; (5):39-43. PubMed ID: 1767958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the efficacy and tolerability of 2 plasma substitutes used as vascular-loading solutions during plasma exchange].
    Bombail-Girard D; Boulechfar H; Tangre M; Landillon N; Bussel A
    Ann Med Interne (Paris); 1990; 141(7):611-4. PubMed ID: 2085241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.